1 January 2024 false No description of principal activity Taxfiler 2024.6 07737587business:PrivateLimitedCompanyLtd2024-01-012024-12-31 077375872023-12-31 077375872024-01-012024-12-31 07737587business:AuditExempt-NoAccountantsReport2024-01-012024-12-31 07737587business:FilletedAccounts2024-01-012024-12-31 077375872024-12-31 07737587business:Director12024-01-012024-12-31 07737587business:Director22024-01-012024-12-31 07737587business:Director32024-01-012024-12-31 07737587business:Director42024-01-012024-12-31 07737587business:CompanySecretary12024-01-012024-12-31 07737587business:RegisteredOffice2024-01-012024-12-31 077375872023-12-31 07737587core:WithinOneYear2024-12-31 07737587core:WithinOneYear2023-12-31 07737587core:ShareCapitalcore:PreviouslyStatedAmount2024-12-31 07737587core:ShareCapitalcore:PreviouslyStatedAmount2023-12-31 07737587core:SharePremiumcore:PreviouslyStatedAmount2024-12-31 07737587core:SharePremiumcore:PreviouslyStatedAmount2023-12-31 07737587core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-12-31 07737587core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-12-31 07737587core:PreviouslyStatedAmount2024-12-31 07737587core:PreviouslyStatedAmount2023-12-31 07737587business:SmallEntities2024-01-012024-12-31 07737587countries:EnglandWales2024-01-012024-12-31 07737587core:PlantMachinery2024-01-012024-12-31 07737587core:Goodwill2023-12-31 07737587core:Goodwill2024-12-31 07737587core:PlantMachinery2023-12-31 07737587core:PlantMachinery2024-12-31 07737587business:OrdinaryShareClass12024-01-012024-12-31 07737587business:OrdinaryShareClass12023-01-012023-12-31 077375872023-01-012023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 07737587 (England and Wales)
Sabal Health and Pharma Ltd Unaudited accounts for the year ended 31 December 2024
Sabal Health and Pharma Ltd Unaudited accounts Contents
Page
- 2 -
Sabal Health and Pharma Ltd Company Information for the year ended 31 December 2024
Directors
T W Goodey J R Heslin S R Williams S Williams
Secretary
Martin Roberts
Company Number
07737587 (England and Wales)
Registered Office
Launchpad Airport Business Park Cherry Orchard Way Rochford Essex SS4 1YH England
- 3 -
Sabal Health and Pharma Ltd Statement of financial position as at 31 December 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Tangible assets
2,708 
4,255 
Current assets
Inventories
437,721 
325,563 
Debtors
259,613 
731,997 
Cash at bank and in hand
329,512 
453,936 
1,026,846 
1,511,496 
Creditors: amounts falling due within one year
(434,978)
(922,360)
Net current assets
591,868 
589,136 
Net assets
594,576 
593,391 
Capital and reserves
Called up share capital
3,774 
3,774 
Share premium
(470,554)
(470,554)
Profit and loss account
1,061,356 
1,060,171 
Shareholders' funds
594,576 
593,391 
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2025 and were signed on its behalf by
T W Goodey Director Company Registration No. 07737587
- 4 -
Sabal Health and Pharma Ltd Notes to the Accounts for the year ended 31 December 2024
1
Statutory information
Sabal Health and Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 07737587. The registered office is Launchpad, Airport Business Park, Cherry Orchard Way, Rochford, Essex, SS4 1YH, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover represents net invoiced sales of goods, excluding value added tax.
Tangible fixed assets policy
Depreciation is provided at the following annual rates in order to write off each assets over its estimated useful life:
Plant & machinery
33% on Cost
Stocks
Stocks and are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Hire Purchase & Leasing Commitments
Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the period of the lease.
- 5 -
Sabal Health and Pharma Ltd Notes to the Accounts for the year ended 31 December 2024
4
Intangible fixed assets
Goodwill 
£ 
Cost
At 1 January 2024
5,000 
At 31 December 2024
5,000 
Amortisation
At 1 January 2024
5,000 
At 31 December 2024
5,000 
Net book value
At 31 December 2024
- 
5
Tangible fixed assets
Plant & machinery 
£ 
Cost or valuation
At cost 
At 1 January 2024
18,530 
At 31 December 2024
18,530 
Depreciation
At 1 January 2024
14,275 
Charge for the year
1,547 
At 31 December 2024
15,822 
Net book value
At 31 December 2024
2,708 
At 31 December 2023
4,255 
6
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
Trade debtors
231,989 
719,674 
Accrued income and prepayments
27,318 
10,198 
Other debtors
306 
2,125 
259,613 
731,997 
7
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
VAT
71,485 
167,808 
Trade creditors
266,724 
589,193 
Taxes and social security
4,982 
38,253 
Other creditors
50,000 
50,000 
Loans from directors
- 
10,250 
Accruals
41,787 
66,856 
434,978 
922,360 
- 6 -
Sabal Health and Pharma Ltd Notes to the Accounts for the year ended 31 December 2024
8
Share capital
2024 
2023 
£ 
£ 
Allotted, called up and fully paid:
3,774 Ordinary shares of £1 each
3,774 
3,774 
9
Average number of employees
During the year the average number of employees was 6 (2023: 6).
- 7 -